<DOC>
	<DOCNO>NCT01562041</DOCNO>
	<brief_summary>The study design evaluate use ETT ECG indices biomarkers assessment atherosclerotic coronary vascular disease ( ASCVD ) .</brief_summary>
	<brief_title>Evaluation Exercise Treadmill Test Indices Patients With Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>History stable coronary artery disease â€¢ Inability unwillingness participate multiple exercise treadmill test and/or requirement study assessed Investigator . History chronic atrial fibrillation . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Exercise Treadmill Test</keyword>
	<keyword>Ranolazine</keyword>
	<keyword>Angina</keyword>
	<keyword>Myocardial ischemia</keyword>
</DOC>